In the STEP 13 clinical trials conducted between 2018 and 2020, semaglutide was shown to significantly reduce inflammatory markers
Mounjaro activates both GIP and GLP-1 receptors, while Ozempic activates GLP-1 only
Some days, you may want a warm bowl of chicken soup with rice
With personalized support and ongoing monitoring, patients can better understand how their appetite may change and stay on track with their weight loss goals
The theoretical risk requires a lifetime contraindication in patients with a personal or family history of medullary thyroid cancer (MTC) or menin-2 (Mary and Curtis 2010
Compounded Semaglutide contains the same active ingredient found in Ozempic and Wegovy the GLP-1 receptor agonist proven to reduce appetite, slow digestion, and drive meaningful, sustainable weight loss